Physician profile
Robert Bruce Canham
NPI 1063706562
$2,157.78
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2022: $1,323 · 2023: $186 · 2024: $264 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.01 |
| Education | $223.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,730.43 | 2019-2025 | Comprehensive Shoulder System, Tapestry, Persona |
| Catalyst Orthoscience | $127.79 | 2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System |
| Sioux Surgical INC | $57.63 | 2025 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Radius Health, INC. | $32.44 | 2023-2025 | Tymlos |
| Heron Therapeutics, INC. | $28.83 | 2025 | Zynrelef |
| Amgen INC. | $28.47 | 2023-2025 | Evenity, Prolia |
| Arthrex, INC. | $27.51 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.22 | 2023 | Strensiq |
| Pfizer INC. | $21.59 | 2023 | |
| Stryker Corporation | $20.93 | 2023 | Iconix, Omega |
| Vertex Pharmaceuticals Incorporated | $19.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Canham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.